Nie, E., Miao, F., Jin, X., Wu, W., Zhou, X., Zeng, A., . . . You, Y. (2018). Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma. Oncogene.
シカゴスタイル引用形Nie, Er, et al. "Fstl1/DIP2A/MGMT Signaling Pathway Plays Important Roles in Temozolomide Resistance in Glioblastoma." Oncogene 2018.
MLA引用形式Nie, Er, et al. "Fstl1/DIP2A/MGMT Signaling Pathway Plays Important Roles in Temozolomide Resistance in Glioblastoma." Oncogene 2018.
警告: この引用は必ずしも正確ではありません.